Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Brian Koss

Concepts (153)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Experimental
2
2020
111
0.780
Why?
Small Molecule Libraries
3
2019
67
0.740
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
59
0.670
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
77
0.660
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2016
11
0.600
Why?
Biomimetic Materials
1
2016
10
0.510
Why?
Proto-Oncogene Proteins
1
2016
150
0.480
Why?
Histones
3
2024
294
0.480
Why?
Peptide Fragments
1
2016
208
0.470
Why?
Cell Lineage
2
2014
83
0.440
Why?
Melanoma
3
2023
278
0.440
Why?
Fusion Proteins, bcr-abl
1
2013
17
0.420
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2013
82
0.390
Why?
Mice
13
2023
5659
0.370
Why?
Cell Line, Tumor
6
2020
1393
0.330
Why?
Apoptosis
8
2023
1092
0.330
Why?
Neoplasms
4
2024
1248
0.320
Why?
Proto-Oncogene Proteins c-bcl-2
4
2014
128
0.300
Why?
Animals
14
2024
13063
0.290
Why?
Antineoplastic Agents
3
2023
1165
0.280
Why?
Ubiquitination
2
2024
42
0.240
Why?
Tumor Microenvironment
3
2023
221
0.230
Why?
Antigen Presentation
1
2023
25
0.220
Why?
Chromatin
1
2024
133
0.210
Why?
Gene Rearrangement
1
2024
63
0.210
Why?
Mice, Transgenic
2
2016
537
0.210
Why?
DNA-Activated Protein Kinase
1
2023
21
0.210
Why?
Cell Survival
5
2019
587
0.200
Why?
Mice, Inbred C57BL
4
2016
1796
0.200
Why?
DNA Damage
1
2024
299
0.200
Why?
Leukemia, Myeloid, Acute
1
2024
180
0.190
Why?
Disease Progression
1
2024
825
0.180
Why?
Hematologic Neoplasms
1
2023
99
0.180
Why?
Tumor Suppressor Protein p53
1
2023
212
0.180
Why?
Histone Code
2
2020
30
0.180
Why?
Epigenesis, Genetic
2
2020
371
0.170
Why?
Transcription Factors
2
2023
561
0.160
Why?
Xenograft Model Antitumor Assays
2
2019
210
0.160
Why?
Polycomb Repressive Complex 2
1
2019
46
0.160
Why?
Integrin alpha Chains
1
2019
9
0.160
Why?
Tumor Cells, Cultured
2
2019
453
0.160
Why?
Cell Cycle Checkpoints
1
2019
29
0.150
Why?
Melanoma, Experimental
1
2019
40
0.150
Why?
Cadherins
1
2019
61
0.150
Why?
Humans
17
2024
50419
0.150
Why?
Antigens, CD
1
2019
221
0.140
Why?
CTLA-4 Antigen
1
2017
22
0.140
Why?
Programmed Cell Death 1 Receptor
1
2017
37
0.130
Why?
DNA-Binding Proteins
1
2019
410
0.130
Why?
Transfection
1
2016
353
0.120
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2014
1
0.120
Why?
Granulocytes
1
2014
26
0.120
Why?
Drug Resistance, Neoplasm
1
2017
315
0.120
Why?
Myeloid Cells
1
2014
37
0.120
Why?
Protein Processing, Post-Translational
2
2020
155
0.120
Why?
CD8-Positive T-Lymphocytes
3
2023
127
0.110
Why?
Monocytes
1
2014
130
0.110
Why?
Gene Expression Regulation, Leukemic
1
2013
29
0.110
Why?
Antibodies, Monoclonal
1
2017
460
0.100
Why?
Lung Neoplasms
1
2019
597
0.100
Why?
Cells, Cultured
2
2013
1563
0.100
Why?
High-Throughput Screening Assays
1
2012
35
0.100
Why?
B-Lymphocytes
1
2013
171
0.100
Why?
Mitochondria
2
2013
400
0.100
Why?
Peptides
1
2012
220
0.090
Why?
Ubiquitin
1
2010
45
0.080
Why?
Disease Models, Animal
1
2013
1431
0.070
Why?
Ubiquitin-Protein Ligases
2
2024
93
0.070
Why?
T-Lymphocytes
2
2023
325
0.070
Why?
Gene Expression Regulation, Neoplastic
2
2024
831
0.070
Why?
Structure-Activity Relationship
2
2019
391
0.060
Why?
Multiple Myeloma
1
2019
2990
0.060
Why?
Camptothecin
1
2024
15
0.060
Why?
BRCA1 Protein
1
2024
32
0.060
Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
14
0.060
Why?
Proto-Oncogenes
1
2024
27
0.060
Why?
Cell Proliferation
2
2019
980
0.050
Why?
Major Histocompatibility Complex
1
2023
12
0.050
Why?
Interferons
1
2023
38
0.050
Why?
HEK293 Cells
1
2024
209
0.050
Why?
Proto-Oncogene Proteins c-ret
1
2024
32
0.050
Why?
Histocompatibility Antigens Class I
1
2023
46
0.050
Why?
Cell Transformation, Neoplastic
1
2024
182
0.050
Why?
HLA Antigens
1
2023
52
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2024
200
0.050
Why?
Cell Cycle Proteins
1
2024
163
0.050
Why?
DNA Repair
1
2024
187
0.050
Why?
Cell Respiration
2
2013
41
0.050
Why?
Phosphorylation
1
2024
520
0.050
Why?
Antigens, Neoplasm
1
2023
148
0.050
Why?
Microscopy, Electron, Transmission
2
2013
73
0.050
Why?
Protein Kinase Inhibitors
1
2024
204
0.050
Why?
CD4-Positive T-Lymphocytes
1
2023
158
0.050
Why?
Immunotherapy, Adoptive
1
2023
161
0.050
Why?
Proteomics
1
2023
313
0.040
Why?
Promoter Regions, Genetic
1
2023
455
0.040
Why?
DNA
1
2023
534
0.040
Why?
Workflow
1
2020
50
0.040
Why?
Azepines
1
2019
19
0.040
Why?
Oxidative Stress
1
2024
770
0.040
Why?
Methylation
1
2019
117
0.040
Why?
Mice, Inbred NOD
1
2019
89
0.040
Why?
Molecular Dynamics Simulation
1
2019
34
0.040
Why?
Crystallography, X-Ray
1
2019
145
0.040
Why?
Mice, SCID
1
2019
171
0.040
Why?
Drug Evaluation, Preclinical
1
2019
144
0.040
Why?
Protein Structure, Tertiary
1
2019
241
0.040
Why?
Binding Sites
1
2019
362
0.040
Why?
Membrane Potential, Mitochondrial
1
2016
36
0.030
Why?
Immunoprecipitation
1
2016
59
0.030
Why?
Epithelial-Mesenchymal Transition
1
2017
51
0.030
Why?
bcl-X Protein
1
2016
53
0.030
Why?
Drug Design
1
2016
119
0.030
Why?
Drug Discovery
1
2016
84
0.030
Why?
Proteome
1
2017
161
0.030
Why?
Fas-Associated Death Domain Protein
1
2014
6
0.030
Why?
Caspase 8
1
2014
10
0.030
Why?
Minor Histocompatibility Antigens
1
2014
17
0.030
Why?
Neoplasm Transplantation
1
2014
83
0.030
Why?
Immune Tolerance
1
2014
83
0.030
Why?
Coculture Techniques
1
2014
140
0.030
Why?
RNA, Small Interfering
1
2014
208
0.030
Why?
Mice, 129 Strain
1
2013
37
0.030
Why?
Sequence Deletion
1
2013
66
0.030
Why?
bcl-2-Associated X Protein
1
2013
57
0.030
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2013
20
0.030
Why?
Proton-Translocating ATPases
1
2012
9
0.020
Why?
Oxygen Consumption
1
2013
191
0.020
Why?
Mice, Knockout
1
2014
840
0.020
Why?
Membrane Potentials
1
2012
117
0.020
Why?
Cell Differentiation
1
2014
640
0.020
Why?
Models, Molecular
1
2012
333
0.020
Why?
Adenosine Triphosphate
1
2012
230
0.020
Why?
Child
1
2023
6931
0.020
Why?
Myocardium
1
2013
443
0.020
Why?
Hematopoietic System
1
2010
3
0.020
Why?
Leupeptins
1
2010
7
0.020
Why?
Cycloheximide
1
2010
36
0.020
Why?
Embryo, Mammalian
1
2010
61
0.020
Why?
Mutant Proteins
1
2010
36
0.020
Why?
Protein Stability
1
2010
42
0.020
Why?
Half-Life
1
2010
86
0.020
Why?
Alleles
1
2010
252
0.020
Why?
Treatment Outcome
1
2020
5265
0.020
Why?
Proteasome Inhibitors
1
2010
104
0.020
Why?
Dose-Response Relationship, Drug
1
2012
1369
0.020
Why?
Fibroblasts
1
2010
338
0.020
Why?
Signal Transduction
1
2014
1608
0.020
Why?
Muscle, Skeletal
1
2013
786
0.020
Why?
Heart Failure
1
2013
531
0.020
Why?
Cell Line
1
2010
997
0.020
Why?
Mutation
1
2010
1275
0.010
Why?
Female
1
2019
27053
0.010
Why?
Koss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description